Literature DB >> 21672530

Enzymatic and non-enzymatic activities of SHIP-1 in signal transduction and cancer.

Claude Condé1, Geoffrey Gloire, Jacques Piette.   

Abstract

PI3K cascade is a central signaling pathway regulating cell proliferation, growth, differentiation, and survival. Tight regulation of the PI3K signaling pathway is necessary to avoid aberrant cell proliferation and cancer development. Together with SHIP-1, the inositol phosphatases PTEN and SHIP-2 are the gatekeepers of this pathway. In this review, we will focus on SHIP-1 functions. Negative regulation of immune cell activation by SHIP-1 is well characterized. Besides its catalytic activity, SHIP-1 also displays non-enzymatic activity playing role in several immune pathways. Indeed, SHIP-1 exhibits several domains that mediate protein-protein interaction. This review emphasizes the negative regulation of immune cell activation by SHIP-1 that is mediated by its protein-protein interaction.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21672530     DOI: 10.1016/j.bcp.2011.05.031

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  23 in total

Review 1.  IgE-dependent signaling as a therapeutic target for allergies.

Authors:  Donald W MacGlashan
Journal:  Trends Pharmacol Sci       Date:  2012-06-30       Impact factor: 14.819

2.  Peripheral Circulating Exosome-Mediated Delivery of miR-155 as a Novel Mechanism for Acute Lung Inflammation.

Authors:  Kangfeng Jiang; Jing Yang; Shuai Guo; Gan Zhao; Haichong Wu; Ganzhen Deng
Journal:  Mol Ther       Date:  2019-07-15       Impact factor: 11.454

3.  Expression, Purification, Crystallisation and X-ray Crystallographic Analysis of a Truncated Form of Human Src Homology 2 Containing Inositol 5-Phosphatase 2.

Authors:  Johanne Le Coq; Luis Heredia Gallego; Daniel Lietha
Journal:  Protein J       Date:  2016-06       Impact factor: 2.371

4.  Deletion of microRNA-155 reduces autoantibody responses and alleviates lupus-like disease in the Fas(lpr) mouse.

Authors:  To-Ha Thai; Heide Christine Patterson; Duc-Hung Pham; Katalin Kis-Toth; Denise A Kaminski; George C Tsokos
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-26       Impact factor: 11.205

5.  Characterization of AQX-1125, a small-molecule SHIP1 activator: Part 1. Effects on inflammatory cell activation and chemotaxis in vitro and pharmacokinetic characterization in vivo.

Authors:  Grant R Stenton; Lloyd F Mackenzie; Patrick Tam; Jennifer L Cross; Curtis Harwig; Jeffrey Raymond; Judy Toews; Joyce Wu; Nancy Ogden; Thomas MacRury; Csaba Szabo
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

6.  Cytotoxicity of pomegranate polyphenolics in breast cancer cells in vitro and vivo: potential role of miRNA-27a and miRNA-155 in cell survival and inflammation.

Authors:  Nivedita Banerjee; Stephen Talcott; Stephen Safe; Susanne U Mertens-Talcott
Journal:  Breast Cancer Res Treat       Date:  2012-09-02       Impact factor: 4.872

7.  A novel strategy for modulation of MDSC to enhance cancer immunotherapy.

Authors:  Tomar Ghansah
Journal:  Oncoimmunology       Date:  2012-09-01       Impact factor: 8.110

8.  Murine pancreatic adenocarcinoma dampens SHIP-1 expression and alters MDSC homeostasis and function.

Authors:  Shari Pilon-Thomas; Nadine Nelson; Nasreen Vohra; Maya Jerald; Laura Pendleton; Karoly Szekeres; Tomar Ghansah
Journal:  PLoS One       Date:  2011-11-22       Impact factor: 3.240

9.  The inositol phosphatase SHIP-1 inhibits NOD2-induced NF-κB activation by disturbing the interaction of XIAP with RIP2.

Authors:  Claude Condé; Xavier Rambout; Marielle Lebrun; Aurore Lecat; Emmanuel Di Valentin; Franck Dequiedt; Jacques Piette; Geoffrey Gloire; Sylvie Legrand
Journal:  PLoS One       Date:  2012-07-17       Impact factor: 3.240

10.  SHIP-1 Couples to the Dectin-1 hemITAM and Selectively Modulates Reactive Oxygen Species Production in Dendritic Cells in Response to Candida albicans.

Authors:  Noelia Blanco-Menéndez; Carlos Del Fresno; Sandra Fernandes; Enrique Calvo; Ruth Conde-Garrosa; William G Kerr; David Sancho
Journal:  J Immunol       Date:  2015-09-28       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.